Upasana Mehra

Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent

Dean R. Artis, Jack J. Lin, Chao Zhang et al. · Proceedings of the National Academy of Sciences · 2008 · 146 citations · Full text

Metabolic Syndrome, Medicinal Chemistry, Biochemistry +15

The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1

Weiru Wang, Chao Zhang, Adhirai Marimuthu et al. · Proceedings of the National Academy of Sciences · 2005 · 142 citations

Molecular Biology, Transcriptional Regulation, Regulatory Ligands +20

Inhibition of Soluble Epoxide Hydrolase Attenuated Atherosclerosis, Abdominal Aortic Aneurysm Formation, and Dyslipidemia

Le-Ning Zhang, Jon Vincelette, Ying Cheng et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 114 citations · Full text

1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia

Sampath‐Kumar Anandan, Heather K. Webb, Dawn Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 72 citations · Full text

Medicinal Chemistry, Oxysterol, Biochemistry +7

High-Throughput Screening of Formulations to Optimize the Thermal Stability of a Therapeutic Monoclonal Antibody

Anita Niedziela‐Majka, Elaine Kan, Perry Weissburg et al. · SLAS DISCOVERY · 2014 · 51 citations · Full text

Engineering, Biomedical Engineering, Immunotherapy +16